Preclinical evidence suggests that IL-6 might be involved in the initiation, as well as in the progression and maintenance of hypertension through a reduction in nitric oxide bioavailability, an increase in vascular superoxide, regulation of angiotensin II expression, and alterations in vascular function and structure. The gene discussed is AGT; the disease is Hypertension.